We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Analyte-Specific Reagents for Cystic Fibrosis

By HospiMedica staff writers
Posted on 25 May 2004
New analyte-specific reagents (ASR) for the detection of mutations in the gene associated with cystic fibrosis (CF) are now available, according to the manufacturer, Tm Bioscience Corp. More...
(Toronto, Canada).

These Tag-It cystic fibrosis products have been manufactured to ASR specifications. CF carrier screening is currently the world's largest and fastest growing human genetic testing market. The Tag-It CF ASRS will be used by CLIA-certified laboratories to identify 39 mutations and four variants of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. These include the most common genetic mutations that are of interest to commercial diagnostic laboratories and include the mutations recommended by the American College of Medical Genetics.

The Tag-It cystic fibrosis ASRs complement the company's expanding series of Tag-It genetic tests that address the rapid growth in CF carrier testing. All genetic tests from Tm Bioscience are based on the Tm Universal Array Platform, which utilizes a proprietary universal tag system that allows for easy optimization, product development, and expansion. Assays from Tm operate on the Luminex xMAP system, a bead-based instrument growing in popularity in the clinical marketplace.

"Providing our award-winning cystic fibrosis products in the regulatory defined ASR format will be an attractive feature for our customers and will facilitate high volume purchases by larger labs,” said Greg Hines, president and CEO of Tm Bioscience.




Related Links:
Tm Bioscience

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
PACS Workstation
PaxeraView PRO
Radiology System
Riviera SPV AT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.